| Parkinson's disease: mechanisms and models W Dauer, S Przedborski Neuron 39 (6), 889-909, 2003 | 7196 | 2003 |
| Dopamine-modified α-synuclein blocks chaperone-mediated autophagy M Martinez-Vicente, Z Talloczy, S Kaushik, AC Massey, J Mazzulli, ... The Journal of clinical investigation 118 (2), 777-788, 2008 | 838 | 2008 |
| Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP W Dauer, N Kholodilov, M Vila, AC Trillat, R Goodchild, KE Larsen, ... Proceedings of the National Academy of Sciences 99 (22), 14524-14529, 2002 | 736 | 2002 |
| Interplay of LRRK2 with chaperone-mediated autophagy SJ Orenstein, SH Kuo, I Tasset, E Arias, H Koga, I Fernandez-Carasa, ... Nature neuroscience 16 (4), 394-406, 2013 | 689 | 2013 |
| Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice NV Weisstaub, M Zhou, A Lira, E Lambe, J González-Maeso, JP Hornung, ... Science 313 (5786), 536-540, 2006 | 527 | 2006 |
| A critical evaluation of the Braak staging scheme for Parkinson's disease RE Burke, WT Dauer, JPG Vonsattel Annals of Neurology: Official Journal of the American Neurological …, 2008 | 460 | 2008 |
| Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope RE Goodchild, CE Kim, WT Dauer Neuron 48 (6), 923-932, 2005 | 433 | 2005 |
| The kinase domain of mitochondrial PINK1 faces the cytoplasm C Zhou, Y Huang, Y Shao, J May, D Prou, C Perier, W Dauer, EA Schon, ... Proceedings of the National Academy of Sciences 105 (33), 12022-12027, 2008 | 389 | 2008 |
| Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. WT Dauer, RE Burke, P Greene, S Fahn Brain: a journal of neurology 121 (4), 547-560, 1998 | 376 | 1998 |
| Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation RE Goodchild, WT Dauer Proceedings of the National Academy of Sciences 101 (3), 847-852, 2004 | 322 | 2004 |
| The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein RE Goodchild, WT Dauer The Journal of cell biology 168 (6), 855-862, 2005 | 274 | 2005 |
| α‐Synuclein produces a long‐lasting increase in neurotransmitter release S Liu, I Ninan, I Antonova, F Battaglia, F Trinchese, A Narasanna, ... The EMBO journal 23 (22), 4506-4516, 2004 | 265 | 2004 |
| The nuclear envelope as a signaling node in development and disease WT Dauer, HJ Worman Developmental cell 17 (5), 626-638, 2009 | 260 | 2009 |
| Current opinions and areas of consensus on the role of the cerebellum in dystonia VG Shakkottai, A Batla, K Bhatia, WT Dauer, C Dresel, M Niethammer, ... The Cerebellum 16, 577-594, 2017 | 231 | 2017 |
| LRRK2 Parkinson disease mutations enhance its microtubule association LR Kett, D Boassa, CCY Ho, HJ Rideout, J Hu, M Terada, M Ellisman, ... Human molecular genetics 21 (4), 890-899, 2012 | 221 | 2012 |
| The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of … CCY Ho, HJ Rideout, E Ribe, CM Troy, WT Dauer Journal of Neuroscience 29 (4), 1011-1016, 2009 | 203 | 2009 |
| Primary dystonia: molecules and mechanisms LM Tanabe, CE Kim, N Alagem, WT Dauer Nature Reviews Neurology 5 (11), 598-609, 2009 | 201 | 2009 |
| Model-based and model-free machine learning techniques for diagnostic prediction and classification of clinical outcomes in Parkinson’s disease C Gao, H Sun, T Wang, M Tang, NI Bohnen, MLTM Müller, T Herman, ... Scientific reports 8 (1), 7129, 2018 | 196 | 2018 |
| A molecular mechanism underlying the neural-specific defect in torsinA mutant mice CE Kim, A Perez, G Perkins, MH Ellisman, WT Dauer Proceedings of the National Academy of Sciences 107 (21), 9861-9866, 2010 | 166 | 2010 |
| Cholinergic system changes of falls and freezing of gait in Parkinson's disease NI Bohnen, P Kanel, Z Zhou, RA Koeppe, KA Frey, WT Dauer, RL Albin, ... Annals of neurology 85 (4), 538-549, 2019 | 161 | 2019 |
